Article
Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families.
Human mutation - 1 Nov 2005
Tesoriero A A, Wong E M, Jenkins M A, Hopper J L, Brown M A, Chenevix-Trench G, Spurdle A B, Southey M C
Abstract excerpt
Genetic screening of women from multiple-case breast cancer families and other research-based endeavors have identified an extensive collection of germline variations of BRCA1 and BRCA2 that can be classified as deleterious and have clinical relevance. For some variants, such as those in the conserved intronic splice site regions which are highly likely to alter splicing, it is not possible to classify them based...
Topics
- Alternative Splicing
- Breast Neoplasms
- Data Interpretation, Statistical
- Family Health
- Female
- Genes, BRCA1
- Genes, BRCA2
- Genetic Variation
- Humans
- Ovarian Neoplasms
